Welgene Biotech Revenue

In the year 2025, Welgene Biotech had annual revenue of 375.94M TWD with 16.55% growth. Welgene Biotech had revenue of 97.84M in the quarter ending December 31, 2025, with 11.62% growth.

Revenue

375.94M

Revenue Growth

+16.55%

P/S Ratio

1.13

Revenue / Employee

n/a

Employees

n/a

Market Cap

422.97M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	375.94M	53.39M	16.55%
Dec 31, 2024	322.55M	42.00M	14.97%
Dec 31, 2023	280.55M	-41.35M	-12.85%
Dec 31, 2022	321.90M	9.25M	2.96%
Dec 31, 2021	312.65M	-85.45M	-21.46%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Pharmigene	149.25M
Puriblood Medical	117.35M
Sofiva Genomics	385.71M
Kim Forest Enterprise	549.14M
Genetics Generation Advancement	603.11M
DIVA Laboratories	868.84M
BIONET	1.24B

Revenue Rankings